LIGAND PHARMACEUTICALS INC Insider Trading for October 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for October 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Option Exercise | M | 14.47 | 2,688 | 38,895 | 0 | |
| Oct 25 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Option Exercise | M | 21.92 | 1,212 | 26,567 | 3,644 | |
| Oct 25 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Buy | M | 21.92 | 1,212 | 26,567 | 33,663 | 32.5 K to 33.7 K (+3.73 %) |
| Oct 25 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Buy | M | 14.47 | 2,688 | 38,895 | 32,451 | 29.8 K to 32.5 K (+9.03 %) |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 119.30 | 2,329 | 277,850 | 0 | |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 89.75 | 2,754 | 247,172 | 0 | |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 119.30 | 2,329 | 277,850 | 47,639 | 45.3 K to 47.6 K (+5.14 %) |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 89.75 | 2,754 | 247,172 | 45,310 | 42.6 K to 45.3 K (+6.47 %) |
| Oct 12 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Option Exercise | M | 14.47 | 2,000 | 28,940 | 2,688 | |
| Oct 12 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Buy | M | 14.47 | 2,000 | 28,940 | 29,763 | 27.8 K to 29.8 K (+7.20 %) |
| Oct 09 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 253.99 | 2,500 | 634,978 | 42,556 | 45.1 K to 42.6 K (-5.55 %) |
| Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 275.04 | 2,500 | 687,610 | 26,142 | 28.6 K to 26.1 K (-8.73 %) |
| Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 12,000 | 173,640 | 21,675 | |
| Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 2,088 | 20,817 | 37,894 | |
| Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 273.88 | 12,000 | 3,286,560 | 105,388 | 117.4 K to 105.4 K (-10.22 %) |
| Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 12,000 | 173,640 | 117,388 | 105.4 K to 117.4 K (+11.39 %) |
| Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 2,088 | 20,817 | 105,388 | 103.3 K to 105.4 K (+2.02 %) |